Ctxr sec filings
WebSEC Filings. All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. … WebView 13F filing holders of Citius Pharmaceuticals Inc. 13F filings are submitted quarterly to the SEC by hedge funds and other investment managers. WhaleWisdom. 13F Data. Latest 13F Filings; 13F Heat Map; 13F Trend Charts; 13F Stats; Stock 13F Stats; Stock Earnings and Events Calendar ... Funds Holding CTXR (via 13F filings)
Ctxr sec filings
Did you know?
WebDec 12, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Tuesday, December 11, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Wed Dec 12 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebCitius Pharmaceuticals, Inc. Common Stock (CTXR) SEC Filings Nasdaq SEC Filings: CTXR Edit my quotes Citius Pharmaceuticals, Inc. Common Stock (CTXR) 0 Add to Watchlist Add to...
WebDec 22, 2024 · SEC Filings Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Thu Dec 22 2024 Earnings Press Release 8-K Corporate News Citius Pharmaceuticals, Inc. … WebMay 13, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Wednesday, March 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu May 13 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.
WebCitius Pharmaceuticals, Inc. Daily – Vickers Top Buyers & Sellers for 04/08/2024 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider ... WebCitius Pharmaceuticals Inc. SEC filings breakout by MarketWatch. View the CTXR U.S. Securities and Exchange Commission reporting information.
WebApr 3, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-23-026265 Submitted to the SEC: Mon Apr 03 2024 4:05:20 PM …
WebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Friday, February 10, 2024 phishieldWebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Citius Pharmaceuticals Inc phish i miss youWebApr 6, 2024 · SEC Filings Short Interest Social Media Get Citius Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CTXR and its competitors with MarketBeat's FREE daily newsletter. CTXR Media Mentions By Week CTXR Media Sentiment CTXR News Sentiment 0.40 0.51 Average Medical News … phish.in apiWebNov 15, 2024 · Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitter ph is high and alkalinity is lowWebCTXR / Citius Pharmaceuticals Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5 EXTENDED Overview Owners Insiders Short Interest Options Filings Financials … phish in bangorWebJan 9, 2024 · Filings & Forms. All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. … ph is higher than pkaWebFeb 8, 2024 · NASDAQ CTXR opened at $1.42 on Wednesday. Citius Pharmaceuticals, Inc. has a 12 month low of $0.77 and a 12 month high of $2.01. The firm has a market capitalization of $207.62 million, a PE ratio of -6.45 and a beta of 1.41. The company's 50 day simple moving average is $1.11 and its 200 day simple moving average is $1.13. tsp stage 3 ls cam